Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5URS

Crystal Structure of the Catalytic Domain of the Inosine Monophosphate Dehydrogenase from Bacillus anthracis in the complex with IMP and the inhibitor P178

Summary for 5URS
Entry DOI10.2210/pdb5urs/pdb
Related3TSB 3TSD 3USB 4MJM 4MY1 4MY8 4MY9 4MYA 4MYX 4QM1 5urr
DescriptorInosine-5'-monophosphate dehydrogenase, INOSINIC ACID, N-[4-chloro-3-(alpha-D-ribofuranosyloxy)phenyl]-N'-{2-[3-(prop-1-en-2-yl)phenyl]propan-2-yl}urea, ... (9 entities in total)
Functional Keywordsimpdh, tim barrel, delta cbs, structural genomics, center for structural genomics of infectious diseases, csgid, oxidoreductase
Biological sourceBacillus anthracis
More
Total number of polymer chains8
Total formula weight333135.82
Authors
Primary citationModi, G.,Marqus, G.M.,Vippila, M.R.,Gollapalli, D.R.,Kim, Y.,Manna, A.C.,Chacko, S.,Maltseva, N.,Wang, X.,Cullinane, R.T.,Zhang, Y.,Kotler, J.L.M.,Kuzmic, P.,Zhang, M.,Lawson, A.P.,Joachimiak, A.,Cheung, A.,Snider, B.B.,Rothstein, D.M.,Cuny, G.D.,Hedstrom, L.
The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for Staphylococcus aureus Infections.
Acs Infect Dis., 7:3062-3076, 2021
Cited by
PubMed Abstract: Many bacterial pathogens, including , require inosine 5'-monophosphate dehydrogenase (IMPDH) for infection, making this enzyme a promising new target for antibiotics. Although potent selective inhibitors of bacterial IMPDHs have been reported, relatively few have displayed antibacterial activity. Here we use structure-informed design to obtain inhibitors of IMPDH (IMPDH) that have potent antibacterial activity (minimal inhibitory concentrations less than 2 μM) and low cytotoxicity in mammalian cells. The physicochemical properties of the most active compounds were within typical Lipinski/Veber space, suggesting that polarity is not a general requirement for achieving antibacterial activity. Five compounds failed to display activity in mouse models of septicemia and abscess infection. Inhibitor-resistant strains readily emerged . Resistance resulted from substitutions in the cofactor/inhibitor binding site of IMPDH, confirming on-target antibacterial activity. These mutations decreased the binding of all inhibitors tested, but also decreased catalytic activity. Nonetheless, the resistant strains had comparable virulence to wild-type bacteria. Surprisingly, strains expressing catalytically inactive IMPDH displayed only a mild virulence defect. Collectively these observations question the vulnerability of the enzymatic activity of IMPDH as a target for the treatment of infections, suggesting other functions of this protein may be responsible for its role in infection.
PubMed: 34590817
DOI: 10.1021/acsinfecdis.1c00342
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.388 Å)
Structure validation

251801

PDB entries from 2026-04-08

PDB statisticsPDBj update infoContact PDBjnumon